ISDA

Deposition Date 2009-08-18

Release Date 2010-08-18

Last Version Date 2023-09-06

Entry Detail

PDB ID:

3IPX

Keywords:

TRANSFERASE/TRANSFERASE INHIBITOR

Title:

X-Ray structure of Human Deoxycytidine Kinase in complex with ADP and an inhibitor

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.00 Å

R-Value Free:

0.27

R-Value Work:

0.22

R-Value Observed:

0.22

Space Group:

P 43 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Deoxycytidine kinase
Gene (Uniprot):DCK
Chain IDs:A
Chain Length:241
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P27707 Pfam ID:PF01712 EC:2.7.1.74

Primary Citation

Lead optimization and structure-based design of potent and bioavailable deoxycytidine kinase inhibitors.

Jessop, T.C, Tarver, J.E, Carlsen, M, Xu, A, Healy, J.P, Heim-Riether, A, Fu, Q, Taylor, J.A, Augeri, D.J, Shen, M, Stouch, T.R, Swanson, R.V, Tari, L.W, Hunter, M, Hoffman, I, Keyes, P.E, Yu, X.C, Miranda, M, Liu, Q, Swaffield, J.C, David Kimball, S, Nouraldeen, A, Wilson, A.G, Foushee, A.M, Jhaver, K, Finch, R, Anderson, S, Oravecz, T, Carson, K.G.Show

Bioorg.Med.Chem.Lett. 19 6784 6787 (2009)

PMID: 19836232 DOI: 10.1016/j.bmcl.2009.09.081

Abstact

A series of deoxycytidine kinase inhibitors was simultaneously optimized for potency and PK properties. A co-crystal structure then allowed merging this series with a high throughput screening hit to afford a highly potent, selective and orally bioavailable inhibitor, compound 10. This compound showed dose dependent inhibition of deoxycytidine kinase in vivo.

Legend

Protein

Chemical

Disease

Primary Citation of related structures